Top 10 Companies in the Southeast Asia Animal‑Derived Chymosin Market (2026): Market Leaders Powering Regional Growth

MARKET INSIGHTS

Global Southeast Asia animal‑derived chymosin market size was valued at USD 48.7 million in 2024. The market is projected to grow from USD 52.4 million in 2025 to USD 86.2 million by 2032, exhibiting a CAGR of 7.3% during the forecast period.

Animal‑derived chymosin is a key proteolytic enzyme traditionally extracted from calf stomachs, used primarily in cheese production to coagulate milk. This enzyme, also known as rennet, specifically cleaves kappa‑casein to initiate milk clotting. While microbial alternatives exist, animal‑derived chymosin remains preferred for traditional cheese varieties due to its superior performance characteristics and clean‑label appeal.

The market growth is driven by expanding dairy production across Southeast Asia, particularly in Indonesia and Vietnam where cheese consumption has grown by 12‑15% annually since 2020. However, supply chain constraints for calf stomachs and growing vegetarian preferences present challenges. Major producers are addressing this through strategic sourcing partnerships, with recent investments in Malaysia’s halal‑certified chymosin production facilities gaining particular traction in Muslim‑majority markets.

Southeast Asia Animal‑Derived Chymosin Market – View in Detailed Research Report

Animal‑derived chymosin is the enzymatic cornerstone of traditional cheese manufacturing. Its unique ability to cleave kappa‑casein with high specificity yields curds that possess the texture and flavor profile expected in European‑style cheeses. The enzyme’s activity profile, stability under varying temperature and pH conditions, and clean‑label status give it a competitive edge over microbial variants, especially in premium and artisanal cheese segments where authenticity is paramount.

Top 10 Companies in the Southeast Asia Animal‑Derived Chymosin Market

1️⃣ Chr. Hansen Holding A/S

Headquarters: Hørsholm, Denmark
Key Offering: Animal‑derived chymosin, microbial chymosin, enzyme technology solutions

Chr. Hansen leverages a robust R&D pipeline focused on enzyme stability and heat tolerance, addressing the challenges posed by tropical climates. Its extensive distribution network across Southeast Asia ensures timely supply for large‑scale cheese producers while maintaining stringent quality controls.

In addition to core enzyme offerings, the company has invested in halal‑certification processes, enabling it to secure contracts in markets such as Malaysia and Indonesia. Partnerships with local dairy cooperatives further reinforce supply chain resilience.

• Heat‑stable chymosin formulations for high‑temperature processing
• Halal‑certified production lines in Malaysia
• Collaborative research with universities on sustainable calf rearing

2️⃣ DuPont Nutrition & Biosciences

Headquarters: Wilmington, USA
Key Offering: Animal‑derived chymosin, enzyme blends, process optimization solutions

DuPont’s global footprint and diversified portfolio provide a competitive advantage in Southeast Asia. The company’s focus on process integration and supply chain optimization allows dairy processors to reduce operational costs while maintaining product quality.

DuPont is expanding its presence through strategic alliances with local distributors and by establishing regional production facilities in Singapore and Kuala Lumpur.

• Integrated enzyme‑process solutions for industrial cheese makers
• Strategic partnerships with local distributors in emerging markets
• Investment in cold‑chain logistics for liquid chymosin

3️⃣ DSM Food Specialties

Headquarters: Heerlen, Netherlands
Key Offering: Animal‑derived chymosin, enzyme technology, dairy ingredient solutions

DSM’s technical expertise in enzyme technology positions it as a trusted partner for major dairy processors in Thailand and Indonesia. Its focus on sustainability and product innovation aligns with the growing demand for premium dairy products.

Through joint ventures and local manufacturing units, DSM has enhanced its market penetration and reduced logistics costs.

• High‑purity chymosin for artisanal cheese producers
• Co‑development of enzyme blends with local dairy processors
• Commitment to carbon‑neutral manufacturing processes

4️⃣ Meito Sangyo Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Animal‑derived chymosin, enzyme purification technology

Meito Sangyo brings advanced purification techniques to the Southeast Asian market, improving yield and reducing impurities. Its strategic acquisitions of local distributors have accelerated market reach.

• Membrane filtration systems for high‑yield extraction
• Acquisition of regional distributors in Vietnam and Malaysia
• Technology transfer agreements with local manufacturers

5️⃣ PT. Kalbe Farma Tbk

Headquarters: Jakarta, Indonesia
Key Offering: Animal‑derived chymosin, pharmaceutical enzymes

Kalbe Farma leverages its extensive pharmaceutical network to distribute chymosin to both dairy and health‑food segments. Its focus on product quality and regulatory compliance has earned it a strong reputation in Indonesia.

• Halal‑certified production lines in Indonesia
• Quality assurance protocols aligned with BPOM regulations
• Partnerships with local dairy farms for raw material sourcing

6️⃣ San Miguel Corporation

Headquarters: Manila, Philippines
Key Offering: Animal‑derived chymosin, dairy ingredient solutions

San Miguel’s deep-rooted presence in the Philippine food sector allows it to provide end‑to‑end solutions for cheese manufacturers. The company’s investment in cold‑chain infrastructure supports consistent supply of liquid chymosin.

• Integrated supply‑chain solutions for dairy processors
• Investment in refrigerated storage facilities
• Collaborations with local dairy farms for sustainable sourcing

7️⃣ Kerry Group

Headquarters: Dublin, Ireland
Key Offering: Animal‑derived chymosin, dairy ingredient blends

Kerry’s focus on functional dairy ingredients aligns with the growing demand for high‑value cheese products. Its emphasis on clean‑label and traceability resonates with health‑conscious consumers.

• Clean‑label chymosin blends for premium cheeses
• Traceability systems for raw material sourcing
• Research on bioactive peptide formation in chymosin‑coagulated cheeses

8️⃣ Arla Foods Ingredients

Headquarters: Copenhagen, Denmark
Key Offering: Animal‑derived chymosin, dairy ingredient solutions

Arla’s emphasis on sustainability and quality positions it well in the Southeast Asian market, where consumers increasingly value clean‑label products. The company’s investment in local production facilities enhances supply reliability.

• High‑purity chymosin for artisanal cheese makers
• Local production units in Thailand and Vietnam
• Carbon‑neutral manufacturing initiatives

9️⃣ Enmex

Headquarters: São Paulo, Brazil
Key Offering: Animal‑derived chymosin, enzyme technology

Enmex’s global expertise in enzyme production is leveraged to supply high‑quality chymosin to Southeast Asian processors. Its focus on cost efficiency and product performance makes it an attractive partner for medium‑scale dairy producers.

• Cost‑effective chymosin formulations for processed cheese
• Technology transfer agreements with local manufacturers
• Continuous improvement in enzyme purification processes

🔟 Sigma‑Aldrich

Headquarters: St. Louis, USA
Key Offering: Animal‑derived chymosin, laboratory enzymes, research solutions

Sigma‑Aldrich’s strong presence in the research and pharmaceutical sectors allows it to provide high‑purity chymosin for specialized applications. Its focus on innovation supports the development of new cheese varieties and functional dairy products.

• High‑purity chymosin for research and development
• Collaboration with academic institutions on peptide research
• Investment in advanced purification technologies

Download FREE Sample Report

Get Full Report

Market Outlook 2026‑2034

The Southeast Asian region is poised for steady expansion of its animal‑derived chymosin market. The convergence of rising dairy consumption, growing middle‑class purchasing power, and increased emphasis on premium cheese products will sustain demand. Regulatory focus on halal certification and food safety standards will shape supply chain dynamics, encouraging local sourcing and investment in production facilities.

Companies that combine technological innovation—such as temperature‑stable chymosin variants and hybrid purification systems—with robust supply‑chain integration will capture the highest growth opportunities. The premium segment, driven by artisanal and specialty cheese producers, offers the most attractive margins, especially in urban centers across Indonesia, Vietnam, and Thailand.

Future Trends

1. Halal‑Certified Production – The expansion of halal‑certified chymosin production lines in Malaysia and Indonesia will unlock new market segments and reduce compliance costs for processors.

2. Supply‑Chain Resilience – Local sourcing initiatives, including partnerships with small‑scale livestock farms and improved cold‑chain infrastructure, will mitigate import volatility and enhance product reliability.

3. Technological Advancements – Next‑generation purification methods, such as membrane filtration and genetic selection of source animals, will increase yield, reduce cost, and improve enzyme stability in tropical climates.

4. Premiumization and Functional Foods – The growing demand for clean‑label, protein‑rich dairy products will drive innovation in chymosin‑coagulated cheese formulations that deliver superior texture and bioactive peptides.